Revance Therapeutics, Inc. Distribution Agreements
8 Contracts & Agreements
- Fifth Amendment to Exclusive Distribution Agreement dated July 29, 2024 by and between Revance Therapeutics, Inc. and Teoxane SA (Filed With SEC on November 7, 2024)
- Fourth Amendment to Exclusive Distribution Agreement dated June 13, 2024 by and between Revance Therapeutics, Inc. and Teoxane SA (Filed With SEC on November 7, 2024)
- Exclusive Distribution Agreement, dated October 24, 2024, by and among Teoxane SA, Revance Therapeutics, Inc. and Revance Australia Pty. Ltd (Filed With SEC on October 28, 2024)
- Sixth Amendment to the Exclusive Distribution Agreement, dated October 24, 2024, by and among Teoxane SA and Revance Therapeutics, Inc (Filed With SEC on October 28, 2024)
- Third Amendment to Exclusive Distribution Agreement dated December 22, 2022, by and between Revance Therapeutics, Inc. and Teoxane SA (Filed With SEC on February 28, 2023)
- Second Amendment to Exclusive Distribution Agreement, dated November 18, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA (Filed With SEC on November 8, 2022)
- First Amendment to Exclusive Distribution Agreement (Filed With SEC on November 9, 2020)
- Exclusive Distribution Agreement, dated January 10, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA (Filed With SEC on February 26, 2020)
